|
"Aspirin
for the older person"
Organised
by the Aspirin Foundation - sponsored by Bayer Pharma AG/Novacyl
Oanisby
the Apirin Foundation - sponsored by Bayer Pharma AG/Novacyl
"Aspirin,
salicylates and cancer"
Organised
by the Aspirin Foundation - sponsored by Bayer Schering Pharma AG
23rd
November - Royal Society of Medicine, London W1
ARRIVE
- one of the largest ever trials of aspirin to prevent first heart
attack and stroke
Aspirin
reduces colon cancer
Results
from the Edinburgh Asymptomatic Atherosclerosis (AAA) Study, Barcelona
Take
aspirin to prevent heart attack and stroke at Beijing Olympics
Aspirin
preventative therapy reduces heart attack and stroke risks
Aspirin
reduces the risk of developing asthma in women
Aspirin
has major role to help reduce global burden of cardiovascular disease
Response
to BMJ Online First article "Aspirin 'resistance' and risks
of CV morbidity
ARRIVE:
A major multinational trial of aspirin as prevention of first heart
attack and stroke
Aspirin
could reduce risk of pre-eclampsia
An
aspirin a day keeps colorectal cancer away
Response
to BMJ Online First article 'Low dose aspirin and cognitive function
in the women's health study cognitive cohort'
Hypertension
study and NSAIDs
Take
aspirin regularly to reduce your chances of getting asthma
FDA
label warnings
"Epidemic
of fear" stopping life-saving aspirin?
Study
shows aspirin and paracetamol reduce fever equally well
Aspirin for
everyone over 50?
|
